Which has higher valuation & earnings, HTFL or DOCS?

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $212.07M 20.73 -$116.79M -$1.83 N/A Doximity $644.86M 8.43 $196.05M $0.85 35.87

Is HTFL or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Doximity 25.48% 18.06% 15.40%

Does the media prefer HTFL or DOCS?

In the previous week, Doximity had 20 more articles in the media than Heartflow. MarketBeat recorded 24 mentions for Doximity and 4 mentions for Heartflow. Heartflow's average media sentiment score of 0.67 beat Doximity's score of 0.20 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 3 Very Positive mention(s) 1 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, HTFL or WAY?

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $212.07M 20.73 -$116.79M -$1.83 N/A Waystar $1.10B 4.65 $112.09M $0.70 38.07

Is HTFL or WAY more profitable?

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% Waystar 11.18% 7.03% 4.75%

Does the media favor HTFL or WAY?

In the previous week, Waystar had 4 more articles in the media than Heartflow. MarketBeat recorded 8 mentions for Waystar and 4 mentions for Heartflow. Waystar's average media sentiment score of 0.71 beat Heartflow's score of 0.67 indicating that Waystar is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waystar 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, SDGR or HTFL?

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 7.48 -$103.26M -$0.74 N/A Heartflow $212.07M 20.73 -$116.79M -$1.83 N/A

Is SDGR or HTFL more profitable?

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Heartflow -55.82% -23.52% -18.66%

Does the media prefer SDGR or HTFL?

In the previous week, Schrodinger had 5 more articles in the media than Heartflow. MarketBeat recorded 9 mentions for Schrodinger and 4 mentions for Heartflow. Heartflow's average media sentiment score of 0.67 beat Schrodinger's score of 0.66 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, CERT or HTFL?

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.37 -$1.60M -$0.45 N/A Heartflow $212.07M 20.73 -$116.79M -$1.83 N/A

Is CERT or HTFL more profitable?

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Heartflow -55.82% -23.52% -18.66%

Does the media favor CERT or HTFL?

In the previous week, Certara had 7 more articles in the media than Heartflow. MarketBeat recorded 11 mentions for Certara and 4 mentions for Heartflow. Certara's average media sentiment score of 0.89 beat Heartflow's score of 0.67 indicating that Certara is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, GDRX or HTFL?

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.50 $30.44M $0.04 87.00 Heartflow $212.07M 20.73 -$116.79M -$1.83 N/A

Is GDRX or HTFL more profitable?

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -55.82%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Heartflow -55.82% -23.52% -18.66%

Heartflow (HTFL) Competitors

$50.31 -0.25 (-0.49%)

As of 01:30 PM Eastern

Compare

HTFL vs. DOCS, WAY, SDGR, CERT, and GDRX

Should you buy Heartflow stock or one of its competitors? Heartflow's main competitors and comparable companies include Doximity (DOCS), Waystar (WAY), Schrodinger (SDGR), Certara (CERT), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Heartflow compare to Doximity?

Heartflow (NASDAQ:HTFL) and Doximity (NYSE:DOCS) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Doximity	25.48%	18.06%	15.40%

Heartflow presently has a consensus target price of $46.25, indicating a potential downside of 8.52%. Doximity has a consensus target price of $31.95, indicating a potential upside of 4.80%. Given Doximity's higher possible upside, analysts clearly believe Doximity is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.24

In the previous week, Doximity had 20 more articles in the media than Heartflow. MarketBeat recorded 24 mentions for Doximity and 4 mentions for Heartflow. Heartflow's average media sentiment score of 0.67 beat Doximity's score of 0.20 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	3 Very Positive mention(s)	1 Positive mention(s)	20 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

87.2% of Doximity shares are held by institutional investors. 7.7% of Heartflow shares are held by company insiders. Comparatively, 31.8% of Doximity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Heartflow has a beta of 2.73, meaning that its stock price is 173% more volatile than the broader market. Comparatively, Doximity has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market.

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$212.07M	20.73	-$116.79M	-$1.83	N/A
Doximity	$644.86M	8.43	$196.05M	$0.85	35.87

Summary

Doximity beats Heartflow on 11 of the 16 factors compared between the two stocks.

How does Heartflow compare to Waystar?

Heartflow (NASDAQ:HTFL) and Waystar (NASDAQ:WAY) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

In the previous week, Waystar had 4 more articles in the media than Heartflow. MarketBeat recorded 8 mentions for Waystar and 4 mentions for Heartflow. Waystar's average media sentiment score of 0.71 beat Heartflow's score of 0.67 indicating that Waystar is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waystar	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
Waystar	11.18%	7.03%	4.75%

Heartflow currently has a consensus price target of $46.25, indicating a potential downside of 8.52%. Waystar has a consensus price target of $34.67, indicating a potential upside of 30.08%. Given Waystar's stronger consensus rating and higher probable upside, analysts clearly believe Waystar is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$212.07M	20.73	-$116.79M	-$1.83	N/A
Waystar	$1.10B	4.65	$112.09M	$0.70	38.07

Heartflow has a beta of 2.73, suggesting that its share price is 173% more volatile than the broader market. Comparatively, Waystar has a beta of 0.18, suggesting that its share price is 82% less volatile than the broader market.

Summary

Waystar beats Heartflow on 13 of the 15 factors compared between the two stocks.

How does Heartflow compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Heartflow	-55.82%	-23.52%	-18.66%

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	7.48	-$103.26M	-$0.74	N/A
Heartflow	$212.07M	20.73	-$116.79M	-$1.83	N/A

79.1% of Schrodinger shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by insiders. Comparatively, 7.7% of Heartflow shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Schrodinger had 5 more articles in the media than Heartflow. MarketBeat recorded 9 mentions for Schrodinger and 4 mentions for Heartflow. Heartflow's average media sentiment score of 0.67 beat Schrodinger's score of 0.66 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Schrodinger has a beta of 1.62, indicating that its stock price is 62% more volatile than the broader market. Comparatively, Heartflow has a beta of 2.73, indicating that its stock price is 173% more volatile than the broader market.

Schrodinger presently has a consensus target price of $22.33, suggesting a potential downside of 13.80%. Heartflow has a consensus target price of $46.25, suggesting a potential downside of 8.52%. Given Heartflow's stronger consensus rating and higher possible upside, analysts plainly believe Heartflow is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.63
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Summary

Schrodinger beats Heartflow on 9 of the 16 factors compared between the two stocks.

How does Heartflow compare to Certara?

Certara (NASDAQ:CERT) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment.

In the previous week, Certara had 7 more articles in the media than Heartflow. MarketBeat recorded 11 mentions for Certara and 4 mentions for Heartflow. Certara's average media sentiment score of 0.89 beat Heartflow's score of 0.67 indicating that Certara is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Certara currently has a consensus target price of $8.60, indicating a potential downside of 6.93%. Heartflow has a consensus target price of $46.25, indicating a potential downside of 8.52%. Given Certara's higher probable upside, equities analysts plainly believe Certara is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.37	-$1.60M	-$0.45	N/A
Heartflow	$212.07M	20.73	-$116.79M	-$1.83	N/A

74.0% of Certara shares are owned by institutional investors. 1.1% of Certara shares are owned by insiders. Comparatively, 7.7% of Heartflow shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Certara has a beta of 1.42, meaning that its stock price is 42% more volatile than the broader market. Comparatively, Heartflow has a beta of 2.73, meaning that its stock price is 173% more volatile than the broader market.

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Heartflow	-55.82%	-23.52%	-18.66%

Summary

Certara beats Heartflow on 11 of the 16 factors compared between the two stocks.

How does Heartflow compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.50	$30.44M	$0.04	87.00
Heartflow	$212.07M	20.73	-$116.79M	-$1.83	N/A

GoodRx presently has a consensus target price of $4.23, indicating a potential upside of 21.47%. Heartflow has a consensus target price of $46.25, indicating a potential downside of 8.52%. Given GoodRx's higher probable upside, equities analysts clearly believe GoodRx is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Heartflow had 3 more articles in the media than GoodRx. MarketBeat recorded 4 mentions for Heartflow and 1 mentions for GoodRx. Heartflow's average media sentiment score of 0.67 beat GoodRx's score of 0.60 indicating that Heartflow is being referred to more favorably in the news media.

Company	Overall Sentiment
GoodRx	Positive
Heartflow	Positive

GoodRx has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market. Comparatively, Heartflow has a beta of 2.73, suggesting that its share price is 173% more volatile than the broader market.

63.8% of GoodRx shares are owned by institutional investors. 5.9% of GoodRx shares are owned by company insiders. Comparatively, 7.7% of Heartflow shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -55.82%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Heartflow	-55.82%	-23.52%	-18.66%

Summary

GoodRx beats Heartflow on 9 of the 17 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HTFL vs. The Competition

Export

Metric	Heartflow	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.35B	$1.93B	$7.18B	$13.17B
Dividend Yield	N/A	3.95%	2.52%	20.73%
P/E Ratio	-27.31	21.95	275.58	25.75
Price / Sales	20.59	93.90	619.65	102.39
Price / Cash	N/A	32.12	27.30	36.12
Price / Book	14.23	6.13	10.71	6.04
Net Income	-$116.79M	-$19.09M	$3.50B	$380.34M
7 Day Performance	-0.93%	-1.38%	-2.47%	-2.69%
1 Month Performance	0.68%	-0.69%	-5.97%	-4.89%
1 Year Performance	51.17%	-19.99%	4.73%	-2.27%

Heartflow Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HTFL Heartflow	1.3087 of 5 stars	$50.22 -0.7%	$46.25 -7.9%	+51.1%	$4.35B	$212.07M	N/A	843
DOCS Doximity	3.7752 of 5 stars	$29.45 +6.3%	$31.95 +8.5%	N/A	$5.25B	$644.86M	34.64	880	Trending News
WAY Waystar	4.2717 of 5 stars	$26.48 +2.8%	$34.67 +30.9%	-25.4%	$5.08B	$1.10B	37.83	1,700
SDGR Schrodinger	2.3116 of 5 stars	$26.39 -3.3%	$20.80 -21.2%	+35.8%	$1.95B	$255.87M	N/A	850	Analyst Forecast High Trading Volume
CERT Certara	1.9859 of 5 stars	$8.64 -3.6%	$8.60 -0.5%	-22.1%	$1.32B	$418.84M	N/A	1,576	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 10/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Heartflow (HTFL) Competitors